Twice-Yearly HIV prevention shot tested in drug users
NCT ID NCT06101342
First seen Mar 06, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looks at a new long-acting shot called lenacapavir, given every 6 months, to prevent HIV in people who inject drugs. About 181 participants in the US will receive either the shot or daily pills. The goal is to see how well the drug works in the body and if it is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston AIDS Research Team CRS
Houston, Texas, 77030, United States
-
ICAP at Columbia University- Bronx Prevention Center
The Bronx, New York, 10451, United States
-
Johns Hopkins Medicine Institute for Clinical and Translational Research, Clinical Research
Baltimore, Maryland, 21287, United States
-
Rutgers New Jersey Medical School, Department of Medicine
Newark, New Jersey, 07103, United States
-
UCLA Vine Street Clinic
Los Angeles, California, 90038, United States
-
UCSD AntiViral Research Center (AVRC)
San Diego, California, 92103, United States
-
University of Miami - Converge Miami Building
Miami, Florida, 33136, United States
-
University of Pennsylvania, Division of Infectious Diseases Penn Prevention Research Unit
Philadelphia, Pennsylvania, 19104, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
Conditions
Explore the condition pages connected to this study.